Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.1 | 0.7 |